The trajectory of companies tied to blockbuster drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the loss of exclusivity in key regions has introduced considerable volatility. Investors are now facing the effect of rival medic